Structural perspective on the design of selective DYRK1B inhibitors. https://www.biorxiv.org/content/10.1101/2022.12.23.521429v1?med=mas
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.